Materialise acquires 75% of Engimplan to grow medical 3D printing presence

Materialise acquired 75% of Engimplan, a Brazil-based medical device manufacturer specializing in CMF and orthopedic devices, with revenues of 6 million euros. The acquisition aims to expand Materialise's global presence in medical 3D printing.

“Materialise today acquired 75% of Engimplan, a Brazil-based medical device manufacturer that is a strong national player making innovative CMF and orthopedic devices with revenues of 6 million euros.”3dprint.com

• 1 source
• 3dprint.comMaterialise Acquires Engimplan, To Grow Global presence in the medical industry - 3DPrint.com | Additive Manufacturing BusinessJoris PeelsAug 1, 2019

Summarized from public sources; check the original articles before acting on it.